Welcome to The Grossgold Clinic Cancer Care
We are dedicated to practicing world-class science-based medicine. We now combine this with new integrative therapies. With new testing and new treatments, we can optimize your health and extend your lifespan.
We have developed new cutting-edge therapies for stage IV cancers, cancer metastasis, and cancers unresponsive to traditional therapies. We also specialize in Lyme disease and complex chronic disease. Welcome to the new personalized medicine called Precision medicine. These are unique treatments tailored to each patients’ genes testing. They are targeted therapies unique to each patient based on molecular evaluation and extensive biochemical evaluation
Cancer Testing and Treatment
We are Specialized in the following Diseases.
Personalized Cancer Testing
New personalized, molecular genomic DNA testing for detection, prognosis, therapy, and cancer prevention. New “tailor-made” personalized treatment programs based on your cancer genome and
Cancer Metastasis
The analysis of your cancer genome represents a powerful tool to identify effective chemotherapy and mechanisms of resistance and eventual chemotherapy failure Targeted therapies to reduce
Immunotherapy
The use of checkpoint inhibitors, autologous tumor vaccines, Dendritic cell vaccines with immune optimization. Unleash the power of your immune system. It has revolutionized the treatment…
Chemotherapy
Targeted molecular low-dose chemotherapy based on chemosensitivity and natural substances testing. Low dose metronomic chemotherapy based on your chemosensitivity testing
The difference between tumor free and cancer free
Tumor free means that there are no active tumors that are found on ultrasound, x-ray, CAT scan, MRI, or PET scanning. In addition, or your blood markers are negative or within normal limits. Unfortunately, this is the term used in a large majority of cases. The patient is then told to watch and wait. If it comes back, then generally the patient is on palliative care or get another round of high-dose chemotherapy. This is sometimes accompanied with immunotherapy if indicated.
Cancer free includes everything from the tumor free plus there is no circulating cancer in your blood. The only normal level should be 0. I have monitored people over the years and the goal is to reach 0 and stay there. Maintaining a proactive approach is the key to success.
Cancer Metastasis and RGCC testing
According to “Cancer growth metastasis” 2015 volume 8 metastasis frequently exists prior to the detection of the primary tumor. In addition, metastatic cells may reside in organs in the original host that are not usually the site of detectable secondary tumors. The problem is that metastatic cells can remain dormant for decades after the primary tumor has been removed. Adding to the problem is that dormancy might be reversible and lead to later recurrences. This being the problem it is important to obtain testing from RGCC on a periodic basis.
Cancer Metastasis and RGCC testing
According to “Cancer growth metastasis” 2015 volume 8 metastasis frequently exists prior to the detection of the primary tumor. In addition, metastatic cells may reside in organs in the original host that are not usually the site of detectable secondary tumors. The problem is that metastatic cells can remain dormant for decades after the primary tumor has been removed. Adding to the problem is that dormancy might be reversible and lead to later recurrences. This being the problem it is important to obtain testing from RGCC on a periodic basis.
Types of Cancer We Treat
Brain Cancer
The cancer genome atlas research network has provided new insights into the personalized genomics mutations that drive disease
Breast Cancer
World wide breast cancer is the most frequently diagnosed cancer and the leading cause of death among females. Measure your ne
Colon Cancer
Measure your genomic “driver mutations” and block these critical pathways using targeted low-dose targeted chemotherapy
Kidney Cancer
It is anticipated that in the future kidney cancer will soon become a chronic disorder as we understand the cancer genome.
Lung Cancer
Lung cancer is the leading cause of cancer-related deaths in the United States. Non-small cell lung cancer represents 80%,
Lymphoma
For Hodgkin lymphoma and non-Hodgkin’s lymphoma, new testing allows us to target cancer mutations using low-dose chemotherapy,
Melanoma
The genetic and molecular understanding of melanoma is transforming its treatment. Measure your molecular mutational drivers
Ovarian Cancer
Gynecological cancer research is changing the way we treat ovarian cancer. We can now measure the molecular pathways and block these
Pancreatic Cancer
We can now offer patients promising new therapies based on the new revolutionary genome at testing. By evaluating your cancer biomarkers,
Uterine Cancer
Endometrial cancer is the most common gynecologic malignancy. With new genomic biomarkers, we can develop personalized programs,
Other Cancer
Please call us for an in-depth discussion of your cancer and the treatment modalities from around the world available here